Visits: 1786, Avg visit time (secs): 297,04 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 815 | 45,63% | |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-cvd-recipients.html | 212 | 11,87% |
| /recipients.html | 51 | 2,86% |
| /novo-clinical-t2/efsd-novo-clin-t2-recipients.html | 48 | 2,69% |
| /novartis/efsd-novartis-recipients.html | 44 | 2,46% |
| /lilly/efsd-lilly-recipients.html | 35 | 1,96% |
| /msd/efsd-msd-recipients-islet.html | 35 | 1,96% |
| /amylin/efsd-amylin-recipients.html | 31 | 1,74% |
| /servier/efsd-servier-recipients.html | 24 | 1,34% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 22 | 1,23% |
| /sanofi-aventis/contact.html | 22 | 1,23% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 920 | 51,51% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-cvd-recipients.html | 147 | 8,23% |
| /novartis/efsd-novartis-recipients.html | 131 | 7,33% |
| /gsk/efsd-gsk-recipients.html | 29 | 1,62% |
| /novo-clinical-t2/efsd-novo-clin-t2-recipients.html | 22 | 1,23% |
| /amylin/efsd-amylin-recipients.html | 22 | 1,23% |
| /efsd-grant/efsd-clinres-recipients.html | 21 | 1,18% |
| /novo-t2/efsd-novo-t2-recipients.html | 18 | 1,01% |
| /msd/efsd-msd-recipients-islet.html | 18 | 1,01% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 18 | 1,01% |
| /lilly/efsd-lilly-recipients.html | 17 | 0,95% |